Literature DB >> 624168

Reduced left ventricular myocardial blood flow per unit mass in aortic stenosis.

L L Johnson, R R Sciacca, K Ellis, M B Weiss, P J Cannon.   

Abstract

Myocardial blood flow (MBF) per unit mass was measured in 10 patients (pts) with severe aortic stenosis (AS) and no significant aortic insufficiency, normal ejection fractions, and normal coronary arteriograms, using xenon-133 and a multiple crystal scintillation camera. MBF per unit mass was reduced in AS (53 +/- 13 mg/100g.min) in comparison to a group of seven normal control patients (69 +/- 12 ml/100g.min) (P less than 0.05). When normalized for heart rate. MBF remained depressed in aortic stenosis (0.65 +/- 0.11 ml/100 g.beat). MBF/beat was strongly related to peak left ventricular wall stress in both groups (r = 0.97). Individual values of MBF/beat were normalized for peak stress using an analysis of covarience; the adjusted mean values were 0.62 +/- 0.03 ml/100g.beat for the AS patients and 0.84 +/- 0.03 ml/100 g.beat for the control patients. There was no overlap between groups in adjusted MBF per beat. Values of MBF per beat and peak stress for a group of ten cardiomyopathy patients with depressed contractility were observed to fall close to the regression line for AS patients. The results suggest that variability in resting MBF in these AS patients is due primarily to differences in LV stress and that reduction in MBF per beat in this group may be due to reduced contractility.

Entities:  

Mesh:

Year:  1978        PMID: 624168     DOI: 10.1161/01.cir.57.3.582

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Impaired coronary and myocardial flow in severe aortic stenosis is associated with increased apoptosis: a transthoracic Doppler and myocardial contrast echocardiography study.

Authors:  L Galiuto; M Lotrionte; F Crea; A Anselmi; G G L Biondi-Zoccai; F De Giorgio; A Baldi; F Baldi; G Possati; M Gaudino; G W Vetrovec; A Abbate
Journal:  Heart       Date:  2005-05-20       Impact factor: 5.994

2.  Profiles of coronary blood flow velocity in patients with aortic stenosis and the effect of valve replacement: a transthoracic echocardiographic study.

Authors:  A Kenny; C R Wisbey; L M Shapiro
Journal:  Br Heart J       Date:  1994-01

3.  Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy.

Authors:  S D Pringle; F G Dunn; A C Tweddel; W Martin; P W Macfarlane; J H McKillop; A R Lorimer; S M Cobbe
Journal:  Br Heart J       Date:  1992-05

4.  Myocardial oxygen consumption in aortic valve disease with and without left ventricular dysfunction.

Authors:  J Schwitter; F R Eberli; M Ritter; M Turina; H P Krayenbuehl
Journal:  Br Heart J       Date:  1992-02

5.  Effects of exerimental right ventricular hypertrophy on myocardial blood flow in conscious dogs.

Authors:  P A Murray; H Baig; M C Fishbein; S F Vatner
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

6.  Complete reversibility of physiological coronary vascular abnormalities in hypertrophied hearts produced by pressure overload in the rat.

Authors:  S Isoyama; N Ito; M Kuroha; T Takishima
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  Propranolol and thyroxine-induced hypertrophic rabbit hearts: effect on heart size and regional O2 supply/consumption variables.

Authors:  G J Grover; J M Houghton; H R Weiss
Journal:  Basic Res Cardiol       Date:  1988 May-Jun       Impact factor: 17.165

8.  Abnormal coronary vascular response to exercise in dogs with severe right ventricular hypertrophy.

Authors:  P A Murray; S F Vatner
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

9.  Determinants and Prognostic Significance of Symptomatic Status in Patients with Moderately Dysfunctional Bicuspid Aortic Valves.

Authors:  Soo Youn Lee; Chi Young Shim; Geu-Ru Hong; In Jeong Cho; Hyuk-Jae Chang; Jong-Won Ha; Namsik Chung
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.